膳食晚期糖基化终产物与遗传风险在炎症性肠病发生中的贡献:一项前瞻性队列研究
基于英国生物银行121,978名基线无炎症性肠病(IBD)的参与者,通过24小时膳食问卷匹配经验证的膳食AGE数据库估算三种常见AGE摄入量,采用Cox比例风险回归分析膳食AGE与IBD风险的关联。中位随访13.72年期间671人发生IBD(192例克罗恩病、478例溃疡性结肠炎)。仅CEL与IBD风险升高相关(HR=1.09,95%CI 1.01-1.18,p=0.020)及CD风险升高相关(HR=1.18,95%CI 1.03-1.36,p=0.014),尤其在超重、缺乏体力活动和不吸烟者中;在CD高遗传风险者中,CML、CEL和MG-H1的CD风险HR分别为1.26、1.41和1.28。膳食AGE与UC风险均无显著关联。
要点
- 膳食CEL摄入与IBD风险升高相关(HR=1.09,95%CI 1.01-1.18,p=0.020)及CD风险升高相关(HR=1.18,95%CI 1.03-1.36,p=0.014)。
- 在CD高遗传风险者中,CML、CEL和MG-H1的CD风险HR分别为1.26(95%CI 1.00-1.57)、1.41(95%CI 1.12-1.77)和1.28(95%CI 1.01-1.62),各p<0.05。
- 膳食AGE与UC风险均无显著关联,无论遗传易感性如何。
核心结论
- 膳食CEL与IBD和CD风险升高相关,但与UC无关。
- 需要进一步干预性研究以支持限制AGE摄入的潜在获益,尤其是CD高遗传风险个体。
研究设计与样本
- 前瞻性队列研究,纳入英国生物银行121,978名基线无IBD的参与者。
- 通过24小时膳食问卷匹配经验证的膳食AGE数据库估算CML、CEL和MG-H1摄入量。
- 采用Cox比例风险回归模型计算膳食AGE与IBD风险的HR和95%CI。
主要发现
- 中位随访13.72年期间,671名参与者发生IBD(192例CD和478例UC)。
- CEL与IBD风险升高相关(HR=1.09,95%CI 1.01-1.18,p=0.020),与CD风险升高相关(HR=1.18,95%CI 1.03-1.36,p=0.014),尤其在超重、缺乏体力活动和不吸烟者中。
- 在CD高遗传风险参与者中,CD的HR(95%CI)为CML 1.26(1.00-1.57)、CEL 1.41(1.12-1.77)、MG-H1 1.28(1.01-1.62),各p<0.05。
- 膳食AGE与UC风险均无显著关联,无论遗传易感性如何。
局限性
- 需要进一步干预性研究以支持限制AGE摄入的潜在获益,尤其是CD高遗传风险个体。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Dietary advanced glycation end products (AGEs) may promote oxidative stress and inflammation in the gastrointestinal tract. AIMS: The aim of this study is to investigate the association between dietary AGE intake and the risk of inflammatory bowel disease (IBD). METHODS: We included 121,978 participants without IBD at baseline from the UK Biobank. We estimated consumption of three common AGEs (Nε-(carboxymethyl)-lysine (CML), Nε-(1-carboxyethyl)-lysine (CEL), and Nδ-(5-hydro-5-methyl-4-imidazolon-2-yl)-ornithine (MG-H1)) by matching 24-h dietary questionnaires to a validated dietary AGE database. We used Cox proportional hazards regression models to calculate the hazard ratio (HR) and 95% CI of the association between dietary AGEs and IBD risk. RESULTS: During a median follow-up of 13.72 years, 671 participants developed IBD (192 with Crohn's disease (CD) and 478 with ulcerative colitis (UC)). Among the assessed dietary AGEs, only CEL was associated with an increased risk of IBD (HR = 1.09, 95% CI: 1.01-1.18, p = 0.020) and CD (HR = 1.18, 95% CI: 1.03-1.36, p = 0.014), particularly for participants who were overweight, physically inactive, and non-smokers. Among participants at a high genetic risk of CD, HRs (95% CI) of CD were 1.26 (1.00-1.57) for CML, 1.41 (1.12-1.77) for CEL, and 1.28 (1.01-1.62) for MG-H1 (p < 0.05 for each). However, none of the dietary AGEs was significantly associated with UC risk, irrespective of genetic predisposition. CONCLUSIONS: Dietary CEL was associated with an increased risk of IBD and CD, but not UC. Further interventional studies are required to support the potential benefit of AGE restriction, especially for individuals at a high genetic risk of CD.
引用
- Jiang F, Yang W, Cao Y, et al. The contribution of dietary advanced glycation end-products and genetic risk in the development of inflammatory bowel disease: a prospective cohort study. Aliment Pharmacol Ther. 2024. PMID: 39177057. doi:10.1111/apt.18218
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。